David B. Roberts - Feb 28, 2025 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Role: President and Director, Director
Signature: /s/ Nathan Ulrich
Stock symbol: LMAT
Transactions as of: Feb 28, 2025
Transactions value $: -$18,646
Form type: 4
Date filed: 3/4/2025, 07:04 PM
Previous filing: Feb 20, 2025
Next filing: Mar 11, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LMAT	Common Stock	Award	$0	+685	+4.67%	$0.00	15.4K	Feb 28, 2025	Direct	F1, F2
transaction	LMAT	Common Stock	Options Exercise	$0	+5	+0.03%	$0.00	15.4K	Feb 28, 2025	Direct	F3
transaction	LMAT	Common Stock	Tax liability	-$18.6K	-203	-1.32%	$91.85	15.2K	Feb 28, 2025	Direct	F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LMAT	Dividend Equivalent Rights	Options Exercise	$0	-5	-27.92%	$0.00	12.9	Feb 28, 2025	Common Stock	5		Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares represent LMAT common stock acquired on February 28, 2025, upon settlement of a Performance Share Unit (PSU) award granted on December 8, 2023. The PSU award vests as follows: 25% upon determination by the Compensation Committee and the balance vests in equal annual installments from the grant date over the next three years.
F2	Each PSU represents a contingent right to receive one share of common stock upon vesting based on the attainment of performance goals.
F3	Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
F4	These shares represent shares withheld by the issuer to satisfy tax withholding obligations incurred upon the vesting of performance stock units awarded to the reporting person on December 8, 2023. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
F5	These dividend equivalent rights were released in connection with the vesting of a performance share unit (PSU) award granted on December 8, 2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.